| Literature DB >> 22084602 |
Abstract
A number of tyrosine plus phenylalanine double auxotrophic mutants were isolated by N-methyl-N-nitro-N-nitrosoguanidine (MNNG) treatment of a locally isolated strain of Aureobacterium flavescens of which 11A(39) and 11A(17) were selected on the basis of their tryptophan production in a mineral salt medium over other isolated mutant strains. The mutational block in the aromatic amino acid biosynthetic pathway of the selected double auxotrophs were determined. By controlling pH of the production medium to near neutrality, the active growth period could be extended up to 72 h and more tryptophan was accumulated compared to pH unregulated culture where the active growth ceased after 48 h. Further improvement of the tryptophan production has been achieved by stepwise isolation of a mutant strain resistant to the tryptophan analogues p-fluorotryptophan (FT) and 5-methyl tryptophan (MT) from the 11A(39). Demand for L-tryptophan as food additive and therapeutic agent is increasing day by day throughout the World, particularly in the underdeveloped and developing countries like India. Still to date India depends on other countries for L-tryptophan. The aim of this work is to develop a potent high yielding, feed back insensitive mutant strain and optimization of its medium pH for maximum production of tryptophan.Entities:
Keywords: 5-methyl tryptophan (MT); Aureobacterium flavescens; analogue resistant mutant; double auxotroph; p-fluorotryptophan (FT); tryptophan
Year: 2011 PMID: 22084602 PMCID: PMC3195219 DOI: 10.4137/IJTR.S5984
Source DB: PubMed Journal: Int J Tryptophan Res ISSN: 1178-6469
Detection of the site of mutational block on the tyrosine and phenylalanine biosynthetic pathway.
| Minima (no amino acid) | ||
| Minimal + phenylalanine | ||
| Minimal + tyrosine | ||
| Minimal + prephenic acid | ||
| Minimal + hydroxyphenyl pyruvate (HPPA) | ||
| Minimal + phenyl pyruvate | ||
| Minimal + phenyl pyruvate + HPPA | ||
| Minimal + phenylalanine + HPPA | ||
| Minimal + tyrosine + phenyl pyruvate | ||
| Minimal + prephenic acid + phenyl pyruvate | ||
| Minimal + tyrosine + phenylalanine | ||
Notes:
‘+’ = growth;
‘−’ = no growth.
Figure 1Site of mutational metabolic block (//) of 11A39 (a) and 11A17 (b).
Figure 2AEffect of maintaining the pH of the medium near neutrality on growth and tryptophan production of the selected strain (pH unregulated).
Determination of the minimum inhibitory concentration (MIC) of FT and MT on the growth of the mutant strains.
| p-flurotryptophan (FT) | 0.00 | +++ | ||
| 0.20 | +++ | |||
| 0.40 | +++ | |||
| 0.60 | ++ | |||
| 0.80 | ++ | |||
| 1.50 | ||||
| 2.50 | ||||
| 3.0 | ||||
| 4.0 | ||||
| 7.5 | ||||
| 10.0 | ||||
| 5-methyl tryptopham (MT) | 0.00 | +++ | ||
| 0.50 | +++ | |||
| 1.0 | +++ | |||
| 2.0 | ++ | |||
| 4.0 | ++ | |||
| 6.0 | ||||
| 10.0 | ||||
| 15.0 | ||||
Notes:
‘+’ = G rowth (Decrease of the number of + sign indicates less growth);
‘−’ = No growth.
L-tryptophan accumulation by FT resistant mutant strains.
| 11A39 | 8.5 | 4.3 |
| 11A39 FTr A1 | 8.5 | 4.3 |
| FTr A6 | 8.5 | 4.3 |
| FTr A10 | 8.3 | 4.3 |
| FTr B2 | 8.5 | 4.5 |
| FTr B6 | 8.5 | 4.3 |
| FTr C4 | 8.3 | 5.0 |
| FTr E1 | 8.0 | 6.4 |
| FTr E2 | 7.9 | 6.1 |
| FTr H1 | 8.0 | 5.8 |
| FTr H2 | 8.1 | 5.8 |
| FTr M1 | 8.1 | 6.2 |
| FTr M2 | 8.1 | 6.5 |
Notes:
a = OD in EEL unit;
b = g/l.
L-tryptophan accumulation by double auxotrophic FT plus MT resistant mutant strains.
| FTr M2 | 8.1 | 6.5 |
| FTMTr A2 | 8.0 | 6.5 |
| FTMTr B4 | 8.1 | 6.6 |
| FTMTr D1 | 8.0 | 6.7 |
| FTMTr E1 | 7.9 | 6.5 |
| FTMTr E2 | 8.0 | 6.6 |
| FTMTr G2 | 7.9 | 6.5 |
Notes:
a = OD in EEL unit;
b = g/l.